These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 18607039)

  • 1. Pharmaceutical policy in China.
    Sun Q; Santoro MA; Meng Q; Liu C; Eggleston K
    Health Aff (Millwood); 2008; 27(4):1042-50. PubMed ID: 18607039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical supply chain in China: current issues and implications for health system reform.
    Yu X; Li C; Shi Y; Yu M
    Health Policy; 2010 Sep; 97(1):8-15. PubMed ID: 20307912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From a national, centrally planned health system to a system based on the market: lessons from China.
    Ma J; Lu M; Quan H
    Health Aff (Millwood); 2008; 27(4):937-48. PubMed ID: 18607026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug policy in China: pharmaceutical distribution in rural areas.
    Dong H; Bogg L; Rehnberg C; Diwan V
    Soc Sci Med; 1999 Mar; 48(6):777-86. PubMed ID: 10190640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals.
    Meng Q; Cheng G; Silver L; Sun X; Rehnberg C; Tomson G
    Health Policy Plan; 2005 May; 20(3):185-96. PubMed ID: 15840634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of China's national essential medicines policy.
    Guan X; Liang H; Xue Y; Shi L
    J Public Health Policy; 2011 Aug; 32(3):305-19. PubMed ID: 21614030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. China's health system and its reform: a review of recent studies.
    Wagstaff A; Yip W; Lindelow M; Hsiao WC
    Health Econ; 2009 Jul; 18 Suppl 2():S7-23. PubMed ID: 19551753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care reform and the pharmaceutical industry.
    Mossinghoff GJ
    Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time trends and determinants of pharmaceutical expenditure in China (1990-2009).
    Shi L; Yang HY; Cheng G; Meng Q
    Pharmacoeconomics; 2014 Mar; 32(3):257-64. PubMed ID: 23827980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical policies in Canada: another example of federal-provincial discord.
    Anis AH
    CMAJ; 2000 Feb; 162(4):523-6. PubMed ID: 10701389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. China's public health-care system: facing the challenges.
    Liu Y
    Bull World Health Organ; 2004 Jul; 82(7):532-8. PubMed ID: 15500285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic analysis of China's health care system: turning a new page.
    Yip W; Wagstaff A; Hsiao WC
    Health Econ; 2009 Jul; 18 Suppl 2():S3-6. PubMed ID: 19551754
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals--strategic considerations in health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S100-11. PubMed ID: 17595837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
    Kong Y
    Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential medicine policy in China: pros and cons.
    Hu S
    J Med Econ; 2013; 16(2):289-94. PubMed ID: 23215958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When incentives and professionalism collide.
    Hsiao WC
    Health Aff (Millwood); 2008; 27(4):949-51. PubMed ID: 18607027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical policy reform in the Russian Federation.
    Rudisill C; Vandoros S; Antoun JG
    J Health Polit Policy Law; 2014 Jun; 39(3):691-705. PubMed ID: 24603082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chinese health system at a crossroads.
    Yip W; Hsiao WC
    Health Aff (Millwood); 2008; 27(2):460-8. PubMed ID: 18332503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical pricing and reimbursement reforms in Greece.
    Yfantopoulos J
    Eur J Health Econ; 2008 Feb; 9(1):87-97. PubMed ID: 17619920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health policy reform in China: lessons from Asia.
    Ramesh M; Wu X
    Soc Sci Med; 2009 Jun; 68(12):2256-62. PubMed ID: 19419809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.